Double indemnity: p53, BRCA and cancer

Nature Medicine

Volumn 3, Issue 7, 1997, Pages 721-722

  Brugarolas, James ^a   Jacks, Tyler ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CANCER; CANCER GENETICS; CANCER RISK; CELL PROLIFERATION; GENE LOCATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

ANIMALS; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; HUMANS; MICE; MUTATION; NEOPLASM PROTEINS; RAD51 RECOMBINASE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030811585     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0797-721     Document Type: Short Survey

References (24)

1. Miki, Y. et al. A strong candidate for the breast and ovarian-cancer susceptibility gene. Science 266, 66-71 (1994).
2. Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792 (1995).
3. Coene, E. et al. BRCA1 is localized in cytoplasmic tube-like invaginations in the nucelus. Nature Genet. 16, 121-123 (1997).
4. Scully, R. et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cells 88, 265-275 (1997).
5. Chapman, M. S. et al. Transcription activation by BRCA1. Nature 382, 678-679 (1996).
6. Milner, J. et al. Transcriptional activation functions in BRCA2. Nature 386, 772-773 (1997).
7. Sharan, S. K. et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804-810 (1997).
8. Shinohara, A. et al. Rad51 protein involved in repair and recombination in S. Cerevesiae is a Rec-A like protein. Cell 69, 457-470 (1992).
9. Carr, A. M. et al. The cellular responses to DNA damage. TICS 5, 32-40 (1995).
10. Lim, D. et al. A mutation in rad 51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16, 7133-7143 (1996).
11. Jacks, T. Tumor suppressor gene mutations in mice. Annu. Rev. Genet. 30, 603-636 (1996).
12. Hakem, R. et al. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009-1023 (1996).
13. Liu, C. et al. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes & Dev. 10, 1835-1843 (1996).
14. Ludwig, T. et al. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes & Dev. 11, 1226-1241 (1997).
15. Suzuki, A. et al. Brca2 is required for embryonic cellular proliferation in the mouse. Genes & Dev. 11, 1242-1252 (1997).
16. El-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
17. Brugarolas, J. et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377, 552-557 (1995).
18. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684 (1995).
19. Hakem, R. et al. Rescue of Brca1 early embryonic lethality by p53 or p21 null mutation. Nature Genet. 16, 298-302 (1997).
20. Tsuzuki, T. et al. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA 93, 6236-6240 (1996).
21. Glebov, O.K. et al. Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res. 54, 3703-3709 (1994).
22. Boyd, M. et al. A human BRCA1 gene knockout. Nature 375, 541-542 (1995).
23. Jones, S.N. et al. Rescue of embryonic lethality in Mdm-2 deficient mice by absence of p53. Nature 378, 206-208 (1996).
24. Montes de Oca Luna, R. et al. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206 (1995).